An Update on Biological and Clinical Associations between E-Cigarettes and Myocardial Infarction

Giuseppe Lippi; Emmanuel J. Favaloro

doi:10.1055/s-0039-3402451

Seminars in Thrombosis and Hemostasis, Inhaltsverzeichnis

Semin Thromb Hemost 2020; 46(04): 512-514
DOI: 10.1055/s-0039-3402451

Letter to the Editor

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

An Update on Biological and Clinical Associations between E-Cigarettes and Myocardial Infarction

Giuseppe Lippi

¹Section of Clinical Biochemistry, University of Verona, Verona, Italy

,

Emmanuel J. Favaloro

²Department of Haematology, Sydney Centers for Thrombosis and Haemostasis, Institute of Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Westmead Hospital, Westmead, NSW, Australia

References
1 Lippi G, Favaloro EJ, Meschi T, Mattiuzzi C, Borghi L, Cervellin G. E-cigarettes and cardiovascular risk: beyond science and mysticism. Semin Thromb Hemost 2014; 40 (01) 60-65
2 Institute for Health Metrics and Evaluation. Global Health Data Exchange. Available at: http://ghdx.healthdata.org/gbd-results-tool . Accessed October 3, 2019
3 Glantz SA. The evidence of electronic cigarette risks is catching up with public perception. JAMA Netw Open 2019; 2 (03) e191032
4 Lippi G, Sanchis-Gomar F. Is it time to be concerned about the effects of e-cigarettes on cardiovascular health?. Expert Rev Cardiovasc Ther 2018; 16 (08) 547-549
5 Christiani DC. Vaping-induced lung injury. N Engl J Med 2019;
6 Pieri L, Chellini E, Gorini G. Smoking fewer cigarettes per day may determine a significant risk reduction in developing smoking attributable diseases? Is there a risk reduction for e-cigarette users? [in Italian]. Epidemiol Prev 2014; 38 (06) 390-393
7 Alzahrani T, Pena I, Temesgen N, Glantz SA. Association between electronic cigarette use and myocardial infarction. Am J Prev Med 2018; 55 (04) 455-461
8 Alzahrani T, Glantz SA. Adding data from 2015 strengthens the association between e-cigarette use and myocardial infarction. Am J Prev Med 2019; 57 (04) 569-571
9 Vindhyal MR, Ndunda P, Munguti C. , et al. Impact on cardiovascular outcomes among e-cigarette users: a review from National Health Interview Surveys. J Am Coll Cardiol 2019; 73: 11
10 Farsalinos KE, Polosa R, Cibella F. , et al. Is e-cigarette use associated with coronary heart disease and myocardial infarction? Insights from the 2016 and 2017 National Health Interview Surveys. Ther Adv Chronic Dis 2019; 10: 2040622319877741
11 Bhatta DN, Glantz SA. Electronic cigarette use and myocardial infarction among adults in the US population assessment of tobacco and health. J Am Heart Assoc 2019; 8 (12) e012317
12 Osei AD, Mirbolouk M, Orimoloye OA. , et al. Association between e-cigarette use and cardiovascular disease among never and current combustible-cigarette smokers. Am J Med 2019; 132 (08) 949-954.e2
13 Ndunda PM, Muutu TM. Electronic cigarette use is associated with a higher risk of stroke. Stroke 2019; 50 (Suppl. 01) A9
14 Qasim H, Karim ZA, Silva-Espinoza JC. , et al. Short-term e-cigarette exposure increases the risk of thrombogenesis and enhances platelet function in mice. J Am Heart Assoc 2018; 7 (15) e009264
15 Nocella C, Biondi-Zoccai G, Sciarretta S. , et al. Impact of tobacco versus electronic cigarette smoking on platelet function. Am J Cardiol 2018; 122 (09) 1477-1481
16 Chen L, Wang T, Yin W. , et al. Exposure to e-vapor extracts alters platelet aggregation, adhesion and activation. FASEB J 2015; 29 (Suppl. 01) Abstract 631.6
17 Hom S, Chen L, Wang T, Ghebrehiwet B, Yin W, Rubenstein DA. Platelet activation, adhesion, inflammation, and aggregation potential are altered in the presence of electronic cigarette extracts of variable nicotine concentrations. Platelets 2016; 27 (07) 694-702